A clinical analysis of erythrocytapheresis for the treatment of polycythemia
Authors:
- Haibo LiuHLHaibo Liu
- Jingzhi ShenJSJingzhi Shen
- Chunhong SunCSChunhong Sun
- Caili GuoCGCaili Guo
- Huan LinHLHuan Lin
- Jianna YaoJYJianna Yao
- Rui MaRMRui Ma
- Mei ZhangMZMei Zhang
- 1 April 2013
- journal article
- clinical trial
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 48 (2) , 229-233
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Erythrocytapheresis versus phlebotomy in the initial treatment of HFE hemochromatosis patients: results from a randomized trialTransfusion, 2011
- Treatment of acute carbon-monoxide poisoning with therapeutic erythrocytapheresis: Clinical effects and results in 17 victimsTransfusion and Apheresis Science, 2010
- How I treat hemochromatosisBlood, 2010
- The 2008 WHO diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosisCurrent Hematologic Malignancy Reports, 2008
- Therapeutic erythrocytapheresis versus phlebotomy in the initial treatment of hereditary hemochromatosis – A pilot studyTransfusion and Apheresis Science, 2007
- Granulocyte Apheresis as a Possible New Approach in Cancer Therapy: A Pilot Study Involving Two CasesCancer Detection Prevention, 1999
- Advantages of Isovolemic Large‐Volume Erythrocytapheresis as a Rapidly Effective and Long‐Lasting Treatment Modality for Red Blood Cell Depletion in Patients with Polycythemia VeraTherapeutic Apheresis, 1997
- Treatment of polycythemia vera by isovolemic large-volume erythrocytapheresisJournal of Molecular Medicine, 1990